FindTrial
Sign In

Baseline factors associated with glycaemic response to treatment with once weekly insulin icodec in type 2 diabetes

Baseline factors associated with glycaemic response to treatment with once weekly insulin icodec in type 2 diabetes

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600128132
Enrollment
Unknown
Registered
2026-07-14
Start date
2025-01-10
Completion date
Unknown
Last updated
2026-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes

Interventions

Type 2 diabetes observation group:None

Sponsors

Xiamen Humanity Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Type 2 diabetes; 2. Normal use of Elioc insulin; 3. Age >= 18 years old

Exclusion criteria

Exclusion criteria: 1. Gestational diabetes, type 1 diabetes, other specific types of diabetes 2. diabetes acute complications: diabetic ketoacidosis, hyperosmolar hyperglycemia 3. Pregnancy, lactation and mental illness

Design outcomes

Primary

MeasureTime frame
Glycated hemoglobin;—

Secondary

MeasureTime frame
C-peptide;Fasting plasma glucose;Serum creatinine;Total cholesterol;Low density lipoprotein cholesterin;Alanine aminotransferase;Aspartate aminotransferase;—

Countries

China

Contacts

Public ContactJianqing Tian

Xiamen Humanity Hospital

449256119@qq.com+86 592 526 2808

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026